ETFs
I
INVA
Innoviva
21.44
+0.24+1.13%After Hours: 21.44 0.00 0.00%19:34 07/24 EDT
OPEN/PREV CLOSE21.41/21.20
TODAY RANGE21.29-21.49
VOL550.44K
MARKET CAP1.58B
52 WEEK RANGE16.52-25.15
AVG VOL (3M)837.09K
% TURNOVER0.75%
TURNOVER--
P/E (TTM)3.551
% RANGE0.94%
EPS(TTM)6.04
P/E(FORWARD)5.70
P/B1.179
BVPS18.18
DIVIDEND--
P/S3.890
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.57B
SHARES OUTSTANDING73.81M
NEXT EARNINGS08/04-08/10
FREE FLOAT73.08M
LOT SIZE1
EX-DATE09/08/2015
News
Press Releases
Financial Reports
Profile
PUBT·5d ago
Armata Pharmaceuticals names David House CFO
Seeking Alpha·07/17 17:06
As Q2 earnings kick off, these small-cap stocks earn an A+ for profitability
PUBT·07/13 11:05
Armata Pharmaceuticals announces press release availability
Simply Wall St·07/08 02:36
Innoviva (INVA) Leaves Russell Indexes, Is The Stock Still Cheap?
Simply Wall St·07/03 13:36
Is Innoviva (INVA) Trading Index Membership for a Deeper Bet on Nortiva Bio’s LYNX Platform?
Simply Wall St·06/28 14:13
Is Innoviva (INVA) Undervalued After Nortiva Bio Launch And XACDURO Deal?
Simply Wall St·06/26 12:22
How Investors Are Reacting To Innoviva (INVA) Expanding Drug Delivery Tech And XACDURO Global Partnership
Dow Jones·06/22 21:20
Innoviva Is Maintained at Buy by BTIG
Dow Jones·06/22 21:20
Innoviva Price Target Maintained With a $42.00/Share by BTIG
Simply Wall St·06/20 23:19
Innoviva (INVA) Stock Could Be 61% Below Fair Value After XACDURO Deal
Same Industry
Name/Symbol
Change%
Price